Thermo Market Capitalization vs Gross Profit Analysis
TMO Stock | USD 577.39 2.80 0.49% |
Thermo Fisher financial indicator trend analysis is much more than just breaking down Thermo Fisher Scientific prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Thermo Fisher Scientific is a good investment. Please check the relationship between Thermo Fisher Market Cap and its Gross Profit accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
Market Cap vs Gross Profit
Market Capitalization vs Gross Profit Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Thermo Fisher Scientific Market Capitalization account and Gross Profit. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Thermo Fisher's Market Capitalization and Gross Profit is 0.45. Overlapping area represents the amount of variation of Market Capitalization that can explain the historical movement of Gross Profit in the same time period over historical financial statements of Thermo Fisher Scientific, assuming nothing else is changed. The correlation between historical values of Thermo Fisher's Market Capitalization and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Market Capitalization of Thermo Fisher Scientific are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Market Capitalization i.e., Thermo Fisher's Market Capitalization and Gross Profit go up and down completely randomly.
Correlation Coefficient | 0.45 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Market Cap
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Thermo Fisher Scientific minus its cost of goods sold. It is profit before Thermo Fisher operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most indicators from Thermo Fisher's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Thermo Fisher Scientific current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. At this time, Thermo Fisher's Selling General Administrative is very stable compared to the past year. As of the 25th of April 2024, Tax Provision is likely to grow to about 469.3 M, while Discontinued Operations is likely to drop (3.6 M).
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 39.2B | 44.9B | 42.9B | 45.0B | Depreciation And Amortization | 2.1B | 3.7B | 3.4B | 3.6B |
Thermo Fisher fundamental ratios Correlations
Click cells to compare fundamentals
Thermo Fisher Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thermo Fisher fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 58.4B | 69.1B | 95.1B | 97.2B | 98.7B | 103.7B | |
Short Long Term Debt Total | 17.8B | 21.7B | 34.9B | 34.5B | 34.9B | 36.7B | |
Other Current Liab | 2.7B | 4.2B | 5.4B | 5.4B | 4.8B | 5.1B | |
Total Current Liabilities | 6.2B | 10.3B | 13.4B | 17.0B | 14.0B | 14.7B | |
Total Stockholder Equity | 29.7B | 34.5B | 40.8B | 44.0B | 46.7B | 49.1B | |
Property Plant And Equipment Net | 5.4B | 6.7B | 9.9B | 10.9B | 9.4B | 9.9B | |
Net Debt | 15.4B | 11.4B | 30.4B | 26.0B | 26.8B | 28.2B | |
Retained Earnings | 22.1B | 28.1B | 35.4B | 41.9B | 47.4B | 49.7B | |
Cash | 2.4B | 10.3B | 4.5B | 8.5B | 8.1B | 8.5B | |
Non Current Assets Total | 45.2B | 45.5B | 72.0B | 69.7B | 74.1B | 77.8B | |
Non Currrent Assets Other | 1.9B | 2.5B | 4.4B | (2.8B) | 4.0B | 4.2B | |
Cash And Short Term Investments | 2.4B | 10.3B | 4.5B | 8.5B | 8.1B | 8.5B | |
Net Receivables | 5.0B | 6.5B | 8.9B | 9.4B | 8.2B | 8.6B | |
Common Stock Shares Outstanding | 403M | 399M | 397M | 394M | 388M | 272.7M | |
Liabilities And Stockholders Equity | 58.4B | 69.1B | 95.1B | 97.2B | 98.7B | 103.7B | |
Non Current Liabilities Total | 17.1B | 19.1B | 32.1B | 28.8B | 37.9B | 39.8B | |
Inventory | 3.4B | 4.0B | 5.1B | 5.6B | 5.1B | 5.3B | |
Other Current Assets | 1.2B | 1.1B | 1.6B | 1.6B | 3.2B | 3.4B | |
Other Stockholder Equity | 7.1B | 6.0B | 4.9B | 1.6B | 2.1B | 2.0B | |
Total Liab | 28.7B | 34.5B | 54.1B | 53.0B | 51.9B | 54.5B | |
Total Current Assets | 11.9B | 22.0B | 20.1B | 25.2B | 24.6B | 25.8B | |
Short Term Debt | 676M | 2.6B | 2.5B | 5.6B | 3.6B | 3.8B | |
Intangible Assets | 14.0B | 12.7B | 20.1B | 17.5B | 16.7B | 17.5B | |
Accounts Payable | 1.9B | 2.2B | 2.9B | 3.4B | 2.9B | 3.0B | |
Property Plant And Equipment Gross | 4.7B | 5.9B | 12.6B | 14.3B | 15.5B | 16.3B | |
Accumulated Other Comprehensive Income | (2.7B) | (2.8B) | (2.3B) | (3.1B) | (3.2B) | (3.1B) | |
Current Deferred Revenue | 916M | 1.3B | 2.7B | 2.6B | 2.7B | 2.8B | |
Good Will | 25.7B | 26.0B | 41.9B | 41.2B | 44.0B | 46.2B | |
Common Stock Total Equity | 434M | 437M | 439M | 441M | 507.2M | 352.8M | |
Short Term Investments | 26M | 31M | 37M | 28M | 1.8M | 1.7M | |
Common Stock | 434M | 437M | 439M | 441M | 442M | 357.4M | |
Other Liab | 4.8B | 5.1B | 8.1B | 5.7B | 6.5B | 6.9B | |
Other Assets | 1.2B | 1.6B | 3.0B | 2.2B | 2.6B | 2.7B | |
Long Term Debt | 17.1B | 19.1B | 32.3B | 28.9B | 31.3B | 32.9B | |
Treasury Stock | (3.7B) | (5.2B) | (6.8B) | (8.9B) | (8.0B) | (7.6B) | |
Property Plant Equipment | 4.7B | 5.9B | 8.3B | 9.3B | 10.7B | 11.2B | |
Net Tangible Assets | (10.1B) | (4.2B) | (21.2B) | (14.5B) | (13.1B) | (13.7B) | |
Retained Earnings Total Equity | 22.1B | 28.1B | 35.4B | 41.9B | 48.2B | 50.6B |
Currently Active Assets on Macroaxis
When determining whether Thermo Fisher Scientific offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Thermo Fisher's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Thermo Fisher Scientific Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Thermo Fisher Scientific Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Thermo Stock analysis
When running Thermo Fisher's price analysis, check to measure Thermo Fisher's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Thermo Fisher is operating at the current time. Most of Thermo Fisher's value examination focuses on studying past and present price action to predict the probability of Thermo Fisher's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Thermo Fisher's price. Additionally, you may evaluate how the addition of Thermo Fisher to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Thermo Fisher's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Thermo Fisher. If investors know Thermo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Thermo Fisher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.054 | Dividend Share 1.4 | Earnings Share 15.46 | Revenue Per Share 111.028 | Quarterly Revenue Growth (0.05) |
The market value of Thermo Fisher Scientific is measured differently than its book value, which is the value of Thermo that is recorded on the company's balance sheet. Investors also form their own opinion of Thermo Fisher's value that differs from its market value or its book value, called intrinsic value, which is Thermo Fisher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Thermo Fisher's market value can be influenced by many factors that don't directly affect Thermo Fisher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Thermo Fisher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thermo Fisher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thermo Fisher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.